The next frontier: Fostering innovation by improving health data access and utilization
Author(s)
Oye, Kenneth A.; Jain, Gagan; Amador, M.; Arnaout, R.; Brown, J. S.; Crown, W.; Ferguson, J.; Pezalla, E.; Rassen, J. A.; Selker, H. P.; Trusheim, M.; Hirsch, Gigi; ... Show more Show less
DownloadOye_et_al-2015-Clinical_Pharmacology_&_Therapeutics.pdf (557.3Kb)
PUBLISHER_CC
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Beneath most lively policy debates sit dry-as-dust theoretical and methodological discussions. Current disputes over the EU Adaptive Pathways initiative and the proposed US 21st Century Cures Act may ultimately rest on addressing arcane issues of data curation, standardization, and utilization. Improved extraction of inform ation on the safety and effectiveness of drugs-in-use must parallel adjustments in evidence requirements at the time of licensing. To do otherwise may compromise safety and efficacy in the name of fostering innovation.
Date issued
2015-08Department
Massachusetts Institute of Technology. Center for Biomedical Innovation; Massachusetts Institute of Technology. Department of Political ScienceJournal
Clinical Pharmacology & Therapeutics
Publisher
Wiley Blackwell
Citation
Oye, KA, G Jain, M Amador, R Arnaout, JS Brown, W Crown, J Ferguson, et al. “The Next Frontier: Fostering Innovation by Improving Health Data Access and Utilization.” Clin. Pharmacol. Ther. 98, no. 5 (September 10, 2015): 514–521.
Version: Final published version
ISSN
00099236
1532-6535